Tuesday, January 13, 2015

Rogbere: Giving Thanks






















EducAid’s Rogbere School was founded in 2010 and usually educates more than 320 students. In 2013, A Call to Business built and opened a home for orphans, many of who are disabled in one way or another, next to the school. We are delighted to be providing education to some of these youngsters.

Unfortunately, numbers in the school now stand at only 46 – 32 boys and 14 girls – around 15% of it’s usual contingent. With 19 staff present, the numbers have remained high despite student numbers dropping. There is a real risk of losing these valuable teachers to other schools or industries, so we have decided that it is most important to keep them in our employ so that we can begin straight back with educating our students once the outbreak has been declared over.

There is, however, no chance for EducAid staff to have been sitting on their laurels. Through our Education by Podcast programme, and our Ebola sensitisation drives, they have been working tirelessly to combat the effects and spread of Ebola. All staff are also working to personal study targets and a professional development programme has been running for all staff throughout the State of Emergency

Suma is the site coordinator at Rogbere School, and this week he spoke with Chief Alie Conteh about the situation in Rogbere community.

As Chief, it is Alie Conteh’s duty to look after the 500 people in his community and to ensure their wellbeing. He has worked with Miriam, Suma, and EducAid to ensure that there is a good relationship between the schools and the community, ensuring that both parties benefit from the relationship. Thank you Suma for the insightful questioning.


As a chief, how did you feel when you heard about Ebola?
I felt bad. Ebola is a killer disease. We pray every day for the end of this sickness. If Ebola enters your house, everybody will die. I am in great fear.


What are the main challenges in your community during this Ebola period?
Soooo many, my brother. The first one is medical facilities, second is our basic food due to the persistent lock down. Nobody is allowed to go to Freetown and nobody from Freetown to visit you. Even if you prepare a small garden to sustain yourself, there will be no way to sell the produce because the roads are blocked.


What strategies have you put in place for the community to be safe since the beginning of this outbreak?
We are very lucky to have EducAid here. When the Ebola disease came down to Freetown, Suma called a meeting of all the elders in the community. Miriam was there and explained to us some of the precautionary measures we should put in place to stop the disease from coming our way. I have also ensured that we do in my community what the president is asking us to do and it is going on well, for instance: frequent hand washing, remembering Sierra Leone in our prayers, and so on. EducAid teachers are doing an awareness every Monday and temperature checking which gives every body hope and confidence in the community


Have you heard of any suspected cases of Ebola?
No. I have not heard of any one in my community.


How about the neighbouring communities?
Yes. Many of them, even one very close to us here in Fogbo village.


And what was your reaction?
Checkpoints to and from the village were installed. Compulsory hand-washing to all passers-by was instituted.


How many people have died during this period in your community? And how did you bury them?
I know of one woman. When I was told about her death I called 117, the alert centre number which was given to us. While waiting for them, some of the family members washed and dressed the corpse. That was the unfortunate thing I heard about some of the people in my village.


So what did you do when you got that information?
Initially, there was a meeting we held up at the school with EducAid teachers and the community elders. We agreed on certain bye-laws and that violators of any of the laws should pay a fine of le 500,000. Such is one of the laws, therefore the fine was levied and a quarantined period of 7 days was given to the family.


What was her lab result?
They said it was not Ebola.


Do you have support from the government with chlorine, veronica buckets, or infrared thermometer as they use in other communities?
No. we have never benefited from any of these, except that A Call to Business gave us some thermometers for which we are very grateful.


Do you have any organisation working in your community? If yes, how have they helped in protecting your community?
Yes. A Call to Business, EducAid, and Corner Stone. EducAid has been very instrumental in educating us about Ebola. They actually made us, and me in particular, see the seriousness of this disease. We appreciate them, and God will bless them for that. Second is A Call to Business; they sent us thermometers, a few veronica buckets, and chlorine; we thank them also.


And Corner Stone?
They have not done anything concerning this Ebola for us.


How do you think the community will be after Ebola?
Happy, and I want to give many thanks to my people for making sure we are safe throughout the outbreak.


How would you assess EducAid to other organisations that you know?
We are poor, we do not have anything, but they are ready to help the community. EducAid is a good organisation for us and we are happy to be with them. We say many thanks to Miriam and the teachers.



Reading the Chief’s words reiterates how important EducAid’s impact is on the small localities where we run our Ebola Sensitisation – and there are many, but also how little support these rural communities are receiving in advance of the spread of Ebola. The response effort has been a constant game of catch-up from both the government and the international community. Despite the great work of charities like EducAid and A Call to Business, the lack of education that persists in the country reveals a distrust of those trying to help, and an inability or unwillingness to follow the procedures that can be life saving. It is only through the outreach programmes such as our Ebola sensitisation that we can reinforce the importance of following such measures.

We hope that you can see the true value of the work that we are doing at EducAid. We’ve had to find new ways to help the most vulnerable members of society, but we can see our work having important and lasting impact.

We’re fighting for a life #AfterEbola, please help.





Thursday, January 8, 2015

A World Free from Ebola: the Vaccines


















It has been widely reported in the press that a new vaccine trial has entered the second round of testing at Oxford University in the UK. Now that reserves of the once-hailed ZMAPP vaccine have run out, the focus of attention has shifted to the major pharmaceutical companies that are working hard to develop a vaccine to stem the tide of Ebola.

I thought that it would be worthwhile to investigate how these drugs are brought to market, and what their impact would be on the situation today, in the coming months, and for the world in the future. Whilst many understand the benefits of a vaccine, it is an alarmingly complex and expensive process for these private companies to embark on, and one that we should all understand our role in facilitating.



How do we combat Ebola currently?
It is well documented that the survival rate of Ebola in Western countries is significantly higher than that in West Africa. The quality of healthcare, an immediate interest in controlling the disease, and the provision of newly developed drugs have all helped to achieve this. Key to achieving a higher survival rate in West Africa has been an early identification of the virus, whilst the provision of fluids and antibiotics dramatically increase the chance of survival. Sufferers of Ebola can lose up to 10 litres of liquids per day through bleeding, vomiting, and diarrhoea, so by replenishing these lost fluids we can help to stop the collapse of vital organs and a further decline of the immune system.

With the healthcare facilities receiving the greatest attention from the world media, it is easy to forget that a portion of the response effort and funding is going in to developing technologies and medicines. In this post we will cover many of the current developments and experimental landscape in the fight against Ebola.

In terms of technology, there is a 15-minute Ebola test being developed by the French Atomic Energy Commission (CEA) went on trial in Guinea in October.[1] The test kit is similar to a pregnancy test and requires only a drop or two of blood or urine to work; we are still awaiting the results of the trial. Simultaneously, a team out of MIT is developing nanotechnology to be able to print active molecules on to paper, to which the Ebola virus will stick. [2] The objective is to have these pieces of paper, similar to a litmus test strip, stored in every First Aid Kit in the region. What is notable and progressive about both of these technologies is that they are designed to be near-immediate low-tech solutions administered at the point of care. This would enable medical staff to isolate and treat the patient whilst avoiding a risky visit to an Ebola treatment centre and potentially further contagion.

Pertinent to this article was the announcement that the World Health Organisation has agreed that it is ethical to use unproven drugs in the current epidemic.[3] This has paved the route for medical trials and experimental drug administration. Whilst in theory this can be lifesaving, the administration of these drugs in a non-laboratory testing environment leads to it’s own issues. In the cases where these innovative drugs have been used, the recipients have been receiving a combination of care and therefore it is difficult to identify which is the active agent in saving them from the virus. For example, Will Pooley, the first NHS health worker to have contracted the virus, was administered the drug ZMAPP along with 7 other Ebola sufferers. Pooley survived, unfortunately two of the seven didn’t. This highlights that the drugs developed are, firstly, not a cure, and secondly, have not achieved the consistency to be called a treatment. In many cases, it is considered that the strength of the patient’s own immune system has, in fact, been a major contributory factor.



What are the options?
Aside from developing drugs, there is another kind of experimental treatment that has gained traction over the last few weeks: convalescent therapies. Convalescent therapy is the process of injecting blood from recovered patients into sick patients, and has had promising results. The New York Times writes that WHO officials are prioritising blood and plasma therapies for treatment, but there are major questions about its safety and efficacy in countries with inefficient health systems and a shortage of medical staff.[4]

As these convalescent therapies are beginning to be instrumented, although it is not clear how widely or effectively, the pharmaceutical companies are drawing on a mix of historical research and international funding in the race to develop an Ebola vaccine. There are three drugs currently on trial that look most likely for a near-future breakthrough.

ZMapp is, for now, out of the picture; there are no more stocks anywhere in the world. The Food and Drug Administration (FDA) in the United States has promised the company more than $42m (£27.6m) to speed up production and trials, but the drug consists of three monoclonal antibodies that have to be grown in the leaves of genetically modified tobacco plants, which takes months. It is also very expensive, which means that mass production for Africa is unlikely.[5]

The centre for Infectious Disease Research & Policy reports that the vaccine currently being trialled at Oxford University is being developed by Johnson & Johnson's Janssen Pharmaceutical Companies. Another drug is being developed by the National Institutes of Health (NIH) and GlaxoSmithKline (GSK) named ChAD3, and another developed by Canadian researchers and licensed by NewLink Genetics and Merck named VSV-EBOV – these latter two are on phase 1 trials as well.

The preclinical studies of the Johnson & Johnson’s vaccine at the National Institutes of Health (NIH) found that, when given 2 months apart, completely protected nonhuman primates against death from the Kikwit Zaire strain of the virus.[6]

According to a statement on their website, the GSK drug ChAd3 uses a type of chimpanzee cold virus, known as chimpanzee adenovirus type 3, as a carrier to deliver genetic material from two strains of the Ebola virus – the Sudan strain and the Zaire strain. It goes on to say that first results show that the vaccine was well-tolerated and produced an immunological response in each of the 20 healthy adult volunteers.[7]

The VSV-EBOV vaccine is made from another virus, V.S.V., for vesicular stomatitis virus that has been used successfully in making other vaccines. The researchers altered V.S.V. by removing one of its genes — rendering the virus harmless — and inserting a gene from Ebola. The transplanted gene forces V.S.V. to sprout Ebola proteins on its surface.[8]

All of the above drugs have had some success in vaccinating primates from the Ebola virus, and all have very different methods of application, so it will be interesting to see which wins the race to market. It is, indeed, the market to which they are heading: we all know that producing drugs is a business, naturally based on profit rather than humanitarian concern, but it is interesting to read about the costs and funding. The development process highlights the central role of NGOs and governments alongside the big pharmaceutical companies.



What are the costs and benefits of developing drugs?
Mahga Kamal-Yanni, Oxfam’s senior health-policy advisor says that “large companies will not invest in research and development for rare and neglected diseases, due to the limited scope for profit. It is neither ethical nor sustainable to leave decisions and financing for research and development to be dictated by the commercial interests of pharmaceutical companies. They will continue producing the medicines that can make the highest profits rather than the therapies that are desperately needed for public health.”[9]

In a New York Times article, Dr. Thomas Geisbert, a member of the team that initially undertook the research on the VSV-EBOV drug 12 years ago, explains the cost-need ratio of the drug industry, and outlines why it has taken so long for his research to be utilised. In this excerpt, he begins talking about the point where he left the drug, after the first round of small trials had been undertaken.

“To that point, the research may have cost a few million dollars, but tests in humans and scaling up production can cost hundreds of millions, and bringing a new vaccine all the way to market typically costs $1 billion to $1.5 billion, Dr. Crowe said. “Who’s going to pay for that?” he asked. “People invest in order to get money back.”[10]

The answer to that question is resolved by the appearance of epidemics such as Ebola. The landscape of research and development funding in a time of crisis makes the pharmaceutical companies more inclined to embark on these ventures. Take, for example, the GSk drug ChAd3. Despite the testing process becomes significantly de-regulated - as pointed out by the WHO announcement on the ethics of administering untested drugs - the big pharmaceutical companies are provided with funds to undertake the development. A high-level emergency meeting between WHO officials and other key players in October insisted that “funding issues should not be allowed to dictate the vaccine agenda.” The minutes concluded that “The funds will be found.”[11] It was announced that for the latest round of testing in Oxford, not to be confused with the Johnson & Johnson testing set underway this week, GSK received a £2.8 million grant from an international consortium consisting of the Wellcome Trust, the Medical Research Council (MRC) and the UK Department for International Development (DFID). The GSK website explains that the consortium’s funding will also enable them to begin manufacturing up to around 10,000 additional doses of the vaccine at the same time as the initial clinical trials, so that if the trials are successful stocks could then be made available immediately by GSK to the WHO to create an emergency immunisation programme for high-risk communities.[12]

Whether you agree with the decision to provide financial and resource-incentive to big pharmaceutical companies, there is little other choice. When the world is gripped by an outbreak on this scale, it is for the international community to financially incentivise those private companies that have the capacity and knowledge to do this.



If we create an effective drug, what is the likely effect on the current outbreak?
Firstly, it is worth noting that vaccines are generally designed to prevent diseases rather than to cure them. However, as may have been in the case of ZMAPP, there is the hope that these vaccines will also have a curative element to them. Only testing and time will answer this question.

GSK writes on their website that, if the phase 1 trials are successful, they can begin the next phases of the clinical trial programme which will involve the vaccination of thousands of frontline healthcare workers in the three affected countries – Sierra Leone, Guinea and Liberia. If the vaccine candidate is able to protect these healthcare workers, it could significantly contribute to efforts to bring this epidemic under control.[13]

A widespread vaccination of medical staff and general public throughout West Africa would paralyse Ebola in it’s tracks. It would represent a cataclysmic blow to the spread of the virus, and would effectively render the crisis over. However, this would not be the end of the vaccine. If this crisis has showed us anything, it is that an early and coordinated response effort is key to controlling the virus and it’s spread.

In 2010 the Sierra Leonean statehouse introduced the Free Health Care Policy which aimed particularly to provide care and protection to mothers and children under 5. As part of this programme, the administration of a a Pentavalent vaccine which is five individual vaccines conjugated in one actively protecta infant children from 5 potentially deadly diseases: Haemophilus Influenza type B (the bacteria that causes meningitis, pneumonia and otitis), Whooping Cough (or Pertussis), Tetanus, Hepatitis B and Diphtheria. In the wake of the Free Health Care Policy, immunisation has been taken up well with 75% of relevant age-groups receiving the immunisation, according to a WHO report. Whether the Ebola vaccine is one that could be added to this mixture, or administered alongside it remains to be seen, and will depend largely on cost and access. What is certain is that the development of a vaccine will be useful in beating the current outbreak and any future outbreaks of this vicious virus.

It is unfortunate that the mechanisms of pharmaceutical development dictate that it takes an epidemic of this proportion to engage the research and development required. However, we should be thankful that the systems and funding are in place to do such development. It will be a long and lasting development that will continue to have positive implications for the future. It will be down the governments of not only West Africa, but all of those countries in Africa where bush meat remains a part of daily life, to ensure that national stocks are maintained to avoid any future Ebola crisis.

Vaccines are in development, and it is surely only a matter of time until they are available for widespread use. Until that point, we must remain on our course of localised isolation, care, and treatment of those pooor souls who contracted Ebola

We’re fighting for a life #AfterEbola, please help.



[1] http://www.meddeviceonline.com/doc/quick-ebola-diagnostic-device-developed-by-french-researchers-0001
[2] http://www.meddeviceonline.com/doc/mit-researchers-develop-rapid-paper-diagnostic-for-ebola-0001
[3] http://www.nytimes.com/interactive/2014/10/23/world/africa/ebola-drugs.html
[4] http://www.nytimes.com/interactive/2014/10/23/world/africa/ebola-drugs.html
[5] http://www.theguardian.com/world/2015/jan/05/ebola-zmapp-stocks-run-out-doctors-turn-alternative-treatments
[6] http://www.cidrap.umn.edu/news-perspective/2015/01/uk-researchers-launch-human-trial-third-ebola-vaccine
[7] http://www.gsk.com/en-gb/media/press-releases/2014/gsk-statement-on-first-phase-1-trial-results-of-a-candidate-ebola-vaccine/
[8] http://www.nytimes.com/2014/10/24/health/without-lucrative-market-potential-ebola-vaccine-was-shelved-for-years.html?_r=0


[9] http://www.independent.co.uk/life-style/health-and-families/health-news/ebola-virus-what-price-for-a-miracle-cure-9785917.html


[10] http://www.nytimes.com/2014/10/24/health/without-lucrative-market-potential-ebola-vaccine-was-shelved-for-years.html?_r=0


[11] http://www.who.int/mediacentre/news/ebola/23-october-2014/en/


[12] http://www.gsk.com/en-gb/media/press-releases/2014/ebola-vaccine-trials-fast-tracked-by-international-consortium/


[13] http://www.gsk.com/en-gb/our-stories/health-for-all/our-contribution-to-the-fight-against-ebola/

Monday, January 5, 2015

4Ms Fighting Ebola: Alfred J Fornah


Alfred J Fornah is a teacher at the Mafoimba School, one of our 4Ms in the Tonkolil district. Mafoimba is a product of our partnership with Make It Happen, a fruitful joint venture that has seen us open 4 schools in one of the most isolated districts in Sierra Leone. As explained in our previous post, the 4Ms schools have been deserted from the beginning of the Ebola outbreak because none of our students are residents at these schools. Instead, our students are having to fend for themselves within their own communities; far from access to education, and from the safety of EducAid, these students are some of the most at-risk within our network.

Our number one priority throughout this Ebola outbreak has been to protect our existing students. Primarily this has been focussed within our schools by restricting movement to that which is absolutely necessary for the continuation of our education, but for those schools that do not have a standing residency of home students we have had to develop more innovative ways to achieve this objective.

Under the careful guidance of Miriam, and by following the strict guidelines of the CDC and WHO, our 4Ms staff have been undertaking a number of Ebola sensitisations throughout the region and surrounding areas. These sensitisations take the education and practical expertises that we know about combatting Ebola, and teaching this to rural communities. In effect, by providing clear information and a practical education to these areas, we are empowering them to protect themselves.

Last week our 4Ms coordinator, Pires, interviewed Alfred J Fornah, a teacher at Mafoimba, so that he could tell us his story. Alfred’s own experience of Ebola has meant that his mission to spread careful information is a personall one: at the beginning of the outbreak Alfred lost his pregnant wife and 1 year old son to this deadly virus. These are exactly the kind of totally avoidable deaths that we are trying to avoid by undertaking our sensitisations.

This is what he Alfred had to say about the work the he and other EducAid staff are doing in Tonkolili.


What is your name, and where are you from?
My name is Alfred J fornah, and I am from Magbaki village, Kolifa Mabang chiefdom in the Tonkolili district. Currently, I live at Mathele Bana village at Mafoimba School.


What are the basic methods to prevent Ebola?
Avoid eating bush meat, especially bats, monkeys and chimpanzees. Avoid public gathering, body contact, and especially important is to not touch the dead and the sick. Anyone suffering from the disease should be isolated, movement should be restricted, and frequent hand-washing with chlorinated water and soap. Frequent taking of malaria drugs like Metaprim helps to prevent malaria, which is often mistaken as one of the symptoms of Ebola.


Can you show us what teaching materials you use to help you to prevent Ebola.
These are the kinds of materials that are circulated to educate people about Ebola.


This is Pires with chlorinated water tanks, ready to distribute to needy communities.


Do you think that the lessons are helping local communities protect themselves?
Yes, the lessons are really helpful to the teachers and the communities as well. I have now taught a very good number of people how to avoid Ebola and what to do if people are showing symptoms.


How has EducAid helped you to keep safe?
We have learnt much through the Ebola sensitization workshop in Port Loko with Miriam, Pires, and Easy man in September. The restriction of my movement to public places, provision of soap and water, Chlorine and drugs. The drugs have been especially helpful for illnesses such as malaria, head aches and stomach aches because they are all often mistaken for symptoms of Ebola. EducAid deems it necessary to give all of these in order to protect its people, both teachers and staff in the community.


What would you have done without EducAid, would you have been able to protect yourself from Ebola?
I would have had to just rely on the Government information and personal preventions, but thank God for EducAid’s country director and the board of trustees for their good support that they have given to us.


What do you think about the work that EducAid is doing against Ebola?
Really, EducAid is doing an excellent work in Sierra Leone in the fight against Ebola. Most especially our Country Director, Miriam Mason-Sesay, who sacrificed herself to see that she protect her students, teachers, and people in the community in the prevention of Ebola.


What are the biggest challenges the country faces regarding Ebola?
There is no education in the country which has led to many dropouts. General hardships include unemployment, closing down of businesses, and people suffering from hunger because they are not allow to move from one place to another. The rate of teenage pregnancy is increasing every day and development activities going on in the country have completely stopped. All of these things are very worrying.



Alfred J Fornah demonstrates the resolve that resides within each and every Sierra Leonean; all that we can do is to give them the tools and support to empower themselves. Imagine losing your wife or husband and new-born; rather than being lost in grief and self-pity, to take arms against the very virus that stole these loved ones from you. It is something that we would all aspire to do, but I wonder how many of us would be able to stomach it. 

Fear is all around, but the fight within Sierra Leone is stronger than Ebola. The recent Civil War that saw such atrocities come from within the country has steeled this nation against attack: Sierra Leone will come out of this fighting, we just need to make sure that the fewest number of innocent people die in the process.

We’re fighting for a life #AfterEbola, please help. Donate here

Saturday, January 3, 2015

Surviving Ebola: Salamatu Conteh



















Salamatu Conteh is a student at EducAid. Over the past few weeks I have asked all of our Site Coordinators to find people who have directly experienced the effects of Ebola, and to interview them so that we can tell their story. Brima is one of EducAid’s most senior staff in Sierra Leone, and he has undertaken a really honest interview with Salamatu so that we can truthfully and faithfully tell her story.

Salamatu’s story is one that encapsulates the human struggle of Ebola; the human struggle that many media outlets forget to tell: that of loss, and of mourning. Fortunately, Salamatu had an education and a home to return to – something that many Sierra Leonean children do not have, and something she came very close to losing.

The past 9 months have been harder on Salamatu than they have been for many; Ebola has ripped a hole right through her family, and all she has left is EducAid. This is her story:

Salamatu is a student at EducAid Lumley, equivalent of the senior secondary level two, and should be sitting the WASSCE exams in a years time. She has been with EducAid for 5 years, starting at Junior Secondary level and has transformed herself from being a weak to mediocre student to being our strongest female science student.

Earlier on this summer, Salamatu recieved the news that her mother had contracted Ebola. Having already lost her aunt, older brother, and her father, Salamatu was distraught. Only days later, her mother had died from the virus.

Here is Brima’s interview with Salamatu:

What is your name, and where are you from?
I am Salamatu Conteh. I am from Waterloo, Western Rural Area, Sierra Leone, where I lived with my family, but I reside in EducAid Lumley.

How has Ebola affected you?
I lost my aunt on 16th September, my elder brother on 24th October, my father on 4th December, and my mother on 17th December.

Were you allowed to visit their funerals?
No, and I felt so miserable.

Were you scared of catching Ebola off your family?
I was terribly afraid. I was lost in thought. Confused over what might have killed them and what to do next.

How did you avoid catching Ebola?
I used the lessons from school in EducAid Lumley: I avoided visiting, touching and attending their funerals and any other. I was terrified.

How has EducAid helped you to keep safe?
Being at EducAid has restricted my movement and contact with Ebola. They have us all on regular treatment to avoid Malaria, worms and malnutrition.

What would you have done without EducAid, would you have been able to protect yourself from Ebola?
I would have done virtually nothing because after the incidences, I was confused and perplexed. Maybe I would have acted wrongly and eventually contracted the disease.

What do you think about the work that EducAid is doing for Ebola?
They are really helping the young and old from keeping out of Ebola’s way and to be safe. They are great!

What are the biggest challenges that the country faces regarding Ebola?
My country lacks the resources and manpower needed to fight and put the disease under control and out of the country. This has affected many of the functions of society and government. Everyone is almost fear stricken.

How are you helping in the fight against Ebola?
I am helping others with the constant reminder of the routines to keep safe: regular washing of hands with chlorinated water, restricting movement and contact, avoiding touching the sick and dead or visiting funeral homes and burial ceremonies, to name a few.



Salamatu’s story is one that is repeated throughout the country: whole families ripped apart by this merciless virus. At EducAid our main priority throughout the outbreak has been to protect our staff and students on our facilities. Our number one objective is to remain Ebola-free, and to achieve this we have some strict policies set out throughout our network. One of these policies is to restrict all of the movement of staff and students to the absolutely necessary minimum. Anyone who contravenes this rule is not allowed to return to our site.

Salamatu, despite all of her education, Ebola training, and sensitisation, in her grief-stricken state did not adhere to these simple rules. Salamatu walked out of the EducAid Lumley compound without permission to collect money for her on the 16th December. This date coincided with the eve of her mother’s death, and it was presumable that she must have been to see her mother who was clearly very ill at the time. Because of this unauthorised trip off of school property, Salamatu was refused re-entry. However, fortunately for her, we had just been granted permits to run our ICCs and she was accepted there. Instead of being in EducAid Lumley, Salamatu is currently in the Maronka Interim Care Centre undergoing an observation period of 21 days. Salamatu is now doing well. She is clearly harrowed by the experience, and feels a deep sense of loss for her parents.

What is inconceivable to anyone who has not been in Salamatu’s position is the feelings of loss and grief that she must have felt when her mother died. Having been stripped of her whole family, Salamatu was left with nobody left to fend for her, and in this daze of fear and grief she made a mistake. Her description of events is telling; she uses phrases such as “terribly afraid”, “terrified”, “I was lost in thought”, “confused and perplexed” to describe her actions. As I have mentioned before, there is no room for mistakes when dealing with Ebola – Ebola mistakes are more often than not deadly. Fortunately for Salamatu it seems as though she will be okay, and will soon be able to rejoin her classmates at Lumley.

Finally, here are a few words from Brima. I asked him to update me on the battle against Ebola:
“Many people are being helped by the EducAid teaching programmes to keep safe. At Maronka, we have helped our entire community keep out of Ebola’s way by not only teaching the instructions but also following up on routines and treatment to make assurance double sure.”



Monday, December 29, 2014

Pastor Anthony Kabia: his Ebola story






















Anthony Kabia is Pastor in Makalie town in the Tonkolili district. The Tonkolili district is the location of EducAid’s most recent developments in our educational network – the 4Ms schools. Mathele Bana, Mafoimba, Makaragube, and Masorie Kargbo are the result of a partnership with Make It Happen (MIH), where MIH were responsible for building the facilities and some on-going funding, and EducAid provides the academic and holistic education.

So far, the partnership has been a hugely successful one. Make It Happen has built some fantastic facilities and, under the guidance of Miriam, Pires, our Site Coordinator, and his support staff have developed these schools in to thriving centres of education for this underserviced region.

The 4Ms schools accept only day students and thus, due to the Ebola situation, we unfortunately have no students there at the moment. The situation in Tonkolili, like many places in Sierra Leone, is worsening. It sits right in the centre of Sierra Leone and therefore experiences through traffic from the surrounding areas, as well as Guinea and Liberia.

Before Ebola, our partnership with Make It Happen helped to develop the 4Ms in to a fantastic place to learn. Now, unfortunately, they are left with only a few teachers within the buildings. However, this has not seen any drop in productivity for the staff members at the 4Ms schools. The teachers have been getting out to local communities and teaching people how to keep safe from Ebola in these dangerous times. With a widespread Ebola sensitisation programme, EducAid’s influence and support is being felt nationwide.

Pires, someone who we have introduced to you before, has been talking with a local Pastor to see what his experience of Ebola has been. This is his conversation with Pastor Anthony Kabia.



What is your name, and where are you from?
My name is Anthony Kabia, I am from Makeni town, and I live with my Family - my mother, father, wife and children.

Have you lost any family or friends to Ebola?
Yes, I have lost two of my children and my brother’s wife. I was unable to attend any of their funerals, and it made me feel terrible. I feel really unhappy about this.


Were you scared of catching Ebola off these people?
Yes. I was very much scared because I use to visit them before the wife was confirmed Ebola positive. As soon as my children had symptoms, we removed them and sent them to hospital immediately but they did not survive.


How did you avoid catching Ebola? Where did you learn these techniques?
I tried very hard to avoid the disease by following the precautions that were announced from our Ebola sensitization meetings, the media, Ebola posters and other Ebola response team. Mostly by not touching the sick, not washing the dead, and isolating the person being suspected of having Ebola. And the washing of hands using chlorinated water plus other Malaria drugs.


How has EducAid helped you to keep safe?
EducAid has helped me to keep safe through the following ways:
1. The Ebola workshop that EducAid conducted at Port Loko, Rolal in September, 2014.
2. Sensitization meetings held to all the 4M Schools by the EducAid Country Director, Pires and Easy Man.
3. By restricting my movement, learnt from the sensitization meetings we have been getting from the above names mentioned.
We may have learnt with the help of the Sierra Leone Government and other Ebola Response teams, by adhering to their messages, but EducAid is really doing an excellent job in the fight of the disease.


What are the biggest challenges that the country faces regarding Ebola?
The following are the challenges that the Government faces:

1. The qualified Doctors who are capable in combating the virus are dying through the Ebola virus.
2. The country resources are not enough to fight the virus.
3. Disbelief of the people that Ebola does not exist in this country; many are thinking that the Government is making money from the virus.
4. Teenage pregnancy is increasing in the country.
5. No schools are in operations now and that people are taken it as opportunity to bear children.


Pastor Anthony has been taking the information that he has gained from the Ebola sensitisation meetings and has been preaching the message of Ebola to his church congregation, as well as many other communities.

It is worrying to hear that there is still a general feeling that the government is somehow behind the virus. Pastor Anthony says that he is also helping to dispel these rumours through preaching, putting up posters, and handing out flyers to spread the facts about Ebola. Many of these lessons have been learnt from our staff throughout Tonkolili.

Our thoughts are with Pires and his team there – keep it up guys.


Support our fight for a life #AfterEbola by clicking here.

Friday, December 26, 2014

Christmas from EducAid

Christmas in Sierra Leone is typically a fun-filled affair. With music, parties, and vibrant atmosphere, the cities, towns and villages are a buzz of excitement. This year was somewhat different; with a strict restriction on public gatherings imposed at the beginning of the Ebola outbreak, it has been a muted festive season.

Just before Christmas the Government of Sierra Leone issued severe warnings against any public gatherings or events over the festive period and New Years Eve. The warnings were issued with a forceful rhetoric and threats of legal consequences for anyone who disobeys. A severe threat for a serious situation.

Fortunately for us our schools are self-contained, and our residents are permanent. We were able to create some wonderful Christmas celebrations, despite all of the horrors going on around us. Miriam said:

“When things are grim and there is such devastation all around, it is wonderful to know that we have so many friends and well-wishers supporting our efforts to protect as many of this country's children from the worst effects of this crisis.



This evening, we have had a little oasis time as we went into serious elf action, preparing 91 Santa socks for early morning delivery.

To all our friends, donors, supporters, we wish you a very Happy Christmas and thank you for all your wonderful support in these difficult times.”

The support that has been shown by all of you, our donors and supporters, has enabled us not only to survive this difficult time, but to prosper. Our schools have continued to deliver a first class study environment to those who are in our schools, whilst our accreditation by the Port Loko District Council this week means that we are able to take in at-risk orphans of Ebola in to quarantine, and integrate them in to our schools. As well as that, we have continued the education of 100s of our students out of school, and to undertake Ebola sensitisations to educate the communities where we work.

The generous contributions from our supporters have come not only in financial support; the logistical support, and much-needed emotional support from different organisations have helped tremendously. Notably the RFA Argus ship, a 100 bed medical support ship sent by the British government, that is currently posted just off shore from Freetown has selected to support EducAid in a charity row.

The row is the brainchild of Petty Officer Diccon Griffith of 820 Naval Air Squadron, who was struck by the plight of youngsters during flights into Port Loko, one of the worst-affected towns in Sierra Leone.

“Each and every face I saw seemed so happy that we were there, many of them quoting the slogan that is seen stickered on many of the UN vehicles out here - togeder, we de fet Ebola – together we will fight Ebola.”


Not only has the ship chosen EducAid to support, but some members of the Argus made a surprise visit to Maronka with nearly 300kg of clothes, toys, and treats. It is these moments of generosity that fill our students with hope for a better life after Ebola. Imagine seeing one of these helicopters with Santa and an Elf jumping out of it to deliver you your Christmas gifts.

To everyone who has helped us in our #AfterEbola programme, and to those who have supported us so ardently over the years to get us to this stage, we say thank you.


Our thoughts are with the students not fortunate enough to be within our school compounds, and are getting through these tough times at home. Our thoughts go out to all of the families and individuals who are suffering under Ebola in the West of Africa. As we identified in a post last week, the accreditation of our Interim Care Centres has marked a turning point in the fight against Ebola. Together, the international and domestic effort will be able to take control of this vicious disease, and soon to overcome it.

Follow the RFA Argus project here, and donate to their fundraising efforts here.

As ever, we need your support. If you can spare some extra money this festive season, there really is no greater cause to which you can send it. Click here to visit our MyDonate page.

Together we are fighting for a life #AfterEbola, please help.

Wednesday, December 24, 2014

A huge step forward: OICCs Operational















“Not everybody who sees this will realise just how hard it might be to secure such a letter.” The letter in question is the Certificate of Authorisation in Port Loko. In this post we’re going to try and give you an insight in to how important this single piece of paper is for our ambitions in combatting Ebola. This letter enables us to do so much of what we have wanted to do, but as yet have not been able to.

As we hope that you’ve gathered by now, we have 3 phases of our Ebola programme:

Phase 1: Ensure security of students and staff on our sites from Ebola.

Phase 2: Continue the education of our students that are on and off site.

Phase 3: Provide for the orphans of Ebola by preparing for their integration in to EducAid schools.













Up until this point, we have not had a single case of Ebola on any of our school sites – by restricting movement to only absolutely necessary travel, and educating our staff and student population for the rare occasions that travel is necessary, we have achieved this feat. This is an on-going phase, and will not be complete until Ebola is eradicated from Sierra Leone in totality. Phase 2 is in full swing. We are recording lessons on to mp3 players, distributing the lessons by WhatsApp, Bluetooth, and any other means possible. We estimate that we’re reaching over 100 students per week, and many others that are not formally part of our network. Phase 3 is now beginning to get in to swing, and the letter mentioned at the top of this post is essential to enabling us to effect real change on the ground.

That letter means that we are able to fully open our Interim Care Centre (ICC) for low-risk orphans, and Observational interim Care Centre (OICC) for at-risk orphans. Here is a brief overview of what each centre will do:

Observational Interim Care Centre – Rolal

The OICC will be taking in the at-risk orphans of Ebola. Up to 24 children needing close medical observation will be accommodated in the smallest groups possible, for example 8 groups of 3. Medical observation will include temperature checking every 3 hours and close observation for any other symptoms. If spotted, an immediate isolation can be achieved and the children will be taken for treatment, maximising their chances of survival. The small groups mean that if one student is diagnosed with Ebola, we do not have to hold back the entire group for a further 21 days – only the children within the same group need to re-start their quarantine period.

EducAid Rolal has isolated one school building and freed up a 10 room staff quarters block for an OICC. A new latrine has been constructed so that the OICC will be self-contained, and some minor adjustments have been made to doors and windows to ensure it’s security.

As soon as children have cleared 21 days, they will be free to go to another home and restart life. Some may want to go back to their communities if they are confident that they will be cared for well there. Some, knowing the poverty in their families, will prefer to stay in EducAid and go to school and make their home with us, only visiting the family periodically.

The centre will be staffed by trained survivors including some nurses. Our newly recruited ‘survivor’ staff were being trained by the Centre for Disease Control (CDC) last week and have been operating since Monday.

We anticipate being able to help at least 30 children a month to re-enter society safely.



Interim Care Centre – Maronka

In addition to the Observation ICC for high-risk cases, we have been running an ICC for low risk but vulnerable children. These might be children who have no carer since their parents died. They may well have already been through quarantine and have in any case not had recent contact with any Ebola sufferer.

There will be far less need for medical observation but temperatures will be checked each day. The children will mingle more normally but stay away from the rest of the village and school until they have cleared 21 days without symptoms, at which point they will be free to join one of the EducAid schools.

Maronka has a teacher training centre that is far away from the rest of the school and has been fenced off. There are latrines on site and water will be brought to the centre by the school community.

We expect to be able to bring at least 25 children in every 21 days. There are currently 29 residents and as some leave others will come. 10 came in yesterday from a community that lost 82 people to Ebola a few months ago.

................................................................................................................


Neither of these projects would have been possible without the authorisation of the local authorities, so we are hugely thankful to everyone that has made it possible for us to achieve this. We know that we are in a great position to cut out Ebola from the very earliest stage, reducing each sufferer’s impact to the bare minimum. With a coordinated local approach to the fight on Ebola, we are sure that we can get it done.

As you can imagine we are severely in need of financial support. All of our programmes are draining the resources of the charity and without the appropriate funding in place our effectiveness will be reduced.

Please consider increasing your direct debit this Christmas, or giving a one off donation.

We are fighting for a life #AfterEbola, please help.